VISTAGEN THERAPEUTICS INC (VTGN)
US92840H4002 - Common Stock
| TTM (2024-9-30) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -39.57M | -29.36M | -59.25M | -47.76M | -17.93M | |||
| Depreciation Amortization | 138.00K | 127.00K | 130.00K | 150.00K | 120.00K | |||
| Change In Working Capital | 2.33M | 793.00K | 5.59M | -1.92M | 3.08M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 10.00K | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other non cash items | 3.61M | 2.63M | 3.82M | 4.27M | 2.67M | |||
| OPERATING CASH FLOW | -33.49M | -25.81M | -49.72M | -45.26M | -12.07M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -164.00K | -61.00K | -210.00K | -200.00K | -280.00K | |||
| Other Investing Activity | N/A | 0.00 | -530.00K | N/A | N/A | |||
| INVESTING CASH FLOW | -13.31M | -61.00K | -740.00K | -200.00K | -280.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 5.00K | -985.00K | -1.04M | 0.00 | -380.00K | |||
| Stock Issued/Repurchased | 129.47M | 129.39M | 170.00K | 6.45M | 114.48M | |||
| Other Financing Activity | N/A | N/A | -170.00K | 4.04M | N/A | |||
| FINANCING CASH FLOW | 93.44M | 128.40M | -1.04M | 10.48M | 114.10M | |||
| CHANGE IN CASH | 46.64M | 102.53M | -51.50M | -34.98M | 101.75M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -33.49M | -25.81M | -49.72M | -45.26M | -12.07M | |||
| Capital Expenditure | -164.00K | -61.00K | -210.00K | -200.00K | -280.00K | |||
| FREE CASH FLOW | -33.65M | -25.87M | -49.93M | -45.46M | -12.35M | |||
All data in USD